Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kassidy Beyerlin"'
Autor:
Siang-Boon Koh, Brian N. Dontchos, Veerle Bossuyt, Christine Edmonds, Simona Cristea, Nsan Melkonjan, Lindsey Mortensen, Annie Ma, Kassidy Beyerlin, Elyssa Denault, Elizabeth Niehoff, Taghreed Hirz, David B. Sykes, Franziska Michor, Michelle Specht, Constance Lehman, Leif W. Ellisen, Laura M. Spring
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-7 (2021)
Abstract Systematic collection of fresh tissues for research at the time of diagnostic image-guided breast biopsy has the potential to fuel a wide variety of innovative studies. Here we report the initial experience, including safety, feasibility, an
Externí odkaz:
https://doaj.org/article/bb4e9fd066134280a9174b2fe59dc262
Autor:
Brian N. Dontchos, Barbara L. Smith, Kassidy Beyerlin, Michelle C. Specht, Annie Ma, Dennis C. Sgroi, Steven J. Isakoff, Christine E Edmonds, Constance D. Lehman, Siang-Boon Koh, Rachel B. Jimenez, Laura Spring, Leif W. Ellisen, Veerle Bossuyt
Publikováno v:
Cancer Research. 80:P2-21
Background: The comprehensive analysis of clinically annotated tissue specimens from those with either benign, high risk or malignant breast findings is critical to improve the understanding of breast cancer biology and treatment. Through a multidisc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10f83d95909d8c8ad1d0e3ddd8449474
https://doi.org/10.1158/1538-7445.sabcs19-p2-21-01
https://doi.org/10.1158/1538-7445.sabcs19-p2-21-01
Autor:
Michelle C. Specht, Geoffrey Fell, Rachel B. Jimenez, Therese M. Mulvey, Beverly Moy, Andrew D. Johnson, Kassidy Beyerlin, Aditya Bardia, Christine E Edmonds, Steven J. Isakoff, Mark L. Zangardi, Veerle Bossuyt, Leif W. Ellisen, Laura Spring
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 27(8)
Introduction The CREATE-X study, conducted in Japan and South Korea, established capecitabine as an adjuvant treatment option for patients with triple negative breast cancer (TNBC) who have residual disease (RD) following neoadjuvant anthracycline or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4634dbca46879198b8fce63977eb814e
https://pubmed.ncbi.nlm.nih.gov/33153384
https://pubmed.ncbi.nlm.nih.gov/33153384
Autor:
Beyerlin, Kassidy, Jimenez, Rachel, Zangardi, Mark, Fell, Geoffrey G, Edmonds, Christine, Johnson, Andrew, Bossuyt, Veerle, Specht, Michelle, Mulvey, Therese M, Moy, Beverly, Ellisen, Leif W, Isakoff, Steven J, Bardia, Aditya, Spring, Laura M
Publikováno v:
Journal of Oncology Pharmacy Practice; Dec2021, Vol. 27 Issue 8, p1883-1890, 8p